ABT vs BSX
Abbott Laboratories · Boston Scientific Corporation
Relative return (rebased to 100)
Key stats
| Metric | ABT | BSX |
|---|---|---|
| Price | $103.87 | $42.99 |
| Market Cap | $179.90B | $62.31B |
| P/E | 27.57 | 21.55 |
| P/B | 3.53 | 2.43 |
| P/S | 4.06 | 3.10 |
| ROE | 12.8% | 11.3% |
| Net Margin | 14.7% | 14.4% |
| Gross Margin | — | 69.0% |
| Revenue Growth | 5.7% | 19.9% |
| Dividend Yield | 2.31% | — |
| EPS | $3.77 | $2.00 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.